On the 26th July 2012, UDG Healthcare announced that they had reached an agreement with Celesio AG to purchase Pharmexx GmbH. The purchase is expected to take place within the next few weeks, subject to regulatory clearances.

The acquisition is a major addition to UDG Healthcare`s rapidly expanding contract sales organisation (CSO) capability and demonstrates their continued confidence in and commitment to this sector.

UDG Healthcare is a leading international healthcare and pharmaceutical services provider, employing around 6,000 people in 35 businesses across the globe. They are listed on both the Irish and UK stock exchanges with an annual turnover of approximately € 1.7 billion.

Pharmexx will join Ashfield Commercial and Medical Services, one of the four divisions of UDG Healthcare. Ashfield Commercial and Medical Services is one of the leading global CSOs and offers a comprehensive and flexible range of solutions in pharmaceutical outsourcing. This includes contract sales and nurse advisory outsourcing, training, marketing services, medical communications/ information services and event management. Ashfield Commercial and Medical Services was established 16 years ago and today has over 4,400 employees with its headquarters in the UK.

Pharmexx, together with UDG Healthcare and the Ashfield Commercial and Medical Services, is in a strong position to further expand its global footprint and service portfolio and will continuously strive to deliver its services and solutions to customers by matching the highest possible standards.